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1. How did the study come about? 
 
The use of large scale epidemiological studies for public health research was pioneered in 
Scotland by Victor Hawthorne in the 1960s. The Midspan studies (so called because they 
were centred around the "mid-span" of life) originated in the post-war drive to control 
pulmonary tuberculosis using Mass Miniature Radiography. The availability of a well-
established and effective method of examining large numbers of apparently healthy 
volunteers suggested the extension of the screening examination to detect a much wider range 
of chronic disease and disability. Midspan is the name given to four separate occupational and 
general population cohort studies based in Scotland which used Hawthorne’s methodology1. 
 
The first study, incorporating Main and Tiree, received funding from the Board of 
Management for Glasgow Northern Hospitals and the Western Regional Hospital Board. It 
was developed in conjunction with the Whitehall study of civil servants in the Greater 
London area. The second study, the Collaborative Study, was undertaken as part of an 
international co-operative study by the European office of the WHO on the prevention of 
ischaemic heart disease and hypertension and was funded by the Scottish Home and Health 
Department. The third study, the Renfrew/Paisley Study, a general population cohort, was 
supported by the Renfrewshire King Edward Memorial Trust and the Scottish Home and 
Health Department. In the 1990s, the most recent study, the Family Study, moved on to study 
the offspring of couples who had taken part in the Renfrew/Paisley study, and was funded by 
the NHS Cardiovascular Research and Development Programme and the Wellcome Trust. 
 
 
2. What does it cover, and how has this changed? 
 
In addition to improving the detection and control of tuberculosis, the general aim was to 
develop an evidence base for the detection and control of cardiorespiratory risks and diseases 
in whole populations. The idea was to pursue the precept that a small reduction in large 
numbers of, say, mild asymptomatic hypertensives, would have a bigger impact on the overall 
health of a total population than treating the relatively small numbers of those with overt 
disease. Cohort studies were needed to identify and measure the risks of dying from coronary 
artery disease, cardiovascular diseases, lung and other cancers and respiratory disease – the 
main causes of excess mortality in west central compared with the rest of Scotland, and in 
Scotland compared with England and Wales. 
 
The Tiree survey investigated (and confirmed) the local belief that blood pressure was higher 
on the island than on the mainland2. 
 
As the cohorts have matured, focus has changed from analyses of cardiorespiratory disease 
risk in relation to risk factors assessed in middle age to consideration of lifecourse influences 
on adult health. More recently, it has been possible to trace the adult offspring of some of the 
4067 married couples who took part in the Renfrew/Paisley study, for studies of 
intergenerational trends and familial aggregation of cardiorespiratory risk, disease and 
associated behaviours. 
 
3. Who is in the sample? and 
4. How often have they been followed up? 
 
 
  
Midspan Cohort Details 
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Main and Tiree  
Date  Baseline study 1964-68 
Cohort (1) Industrial group from 13 factories 
Location  Central belt of Scotland 
Number  3,931 (3,417 male, 514 female)  
Age 15-70 years 
Cohort (2) Population cohort and relatives emigrated to mainland 
Location Isle of Tiree & Glasgow 
Number 762 (338 male, 424 female)  
Age 14-92 years 
     Follow-up  
     Date 1967-70 (2-4 years after baseline) 
     Number Cohort (1) 1,750 (1,530 male, 220 female) 
     Number Cohort (2) 496 (218 male, 278 female) 
  
Collaborative  
Date Baseline study 1970-73 
Cohort Occupational group from 27 workplaces 
Location Central belt of Scotland 
Age Working age 
Number  7,028 (6,022 male, 1,006 female) 
     Follow-up  
     Date 1977 
     Number 3,221 (2,760 male, 461 female) 
  
Renfrew/Paisley  
Date 1972-76 
Cohort General population (78% response rate) 
Location Neighbouring towns on the outskirts of Glasgow 
Age 45-64 years 
Number  15,402 (7,048 male, 8,354 female) 
     Follow-up  
     Date (Renfrew only) 1973 
     Number 2,273 (1,062 male, 1,211 female) 
     Date (Renfrew/Paisley) 1977-79 
     Number 8,402 (3,724 male, 4,678 female) 
  
Family Study  
Date 1996 
Cohort Offspring of married couples in the Renfrew/Paisley 
cohort (73%/84% response rates individuals/families) 
Location West of Scotland 
Age 30-59 years 
Number 2,338 (1,040 sons, 1,298 daughters) from 1477 families.
     Follow-up In 2001 DNA was collected from 556 Renfrew/Paisley 
surviving parents.  
  
 
 
5. What has been measured? 
 
     
 Main and Tiree Collaborative Renfrew/Paisley Family Study 
     
Baseline  Socioeconomic Lifecourse Socioeconomic Health and lifestyle 
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1.  Self-
administered 
questionnaire 
factors  
Health behaviour 
Cardiorespiratory 
measures 
Self-reported 
anthropometric 
measures 
socioeconomic 
factors  
Health behaviour 
Cardiorespiratory 
measures 
Stress 
Education 
 
factors  
Health behaviour 
Cardiorespiratory 
measures 
General health 
questionnaire 
including family 
history and 7 day 
food frequency data 
Birthweights 
2.  Screening 
check 
Physiological 
measures 
Biochemical tests 
on urine 
Anthropometric 
measures  
Physiological tests 
Blood and urine 
samples for 
biochemical analyses  
Anthropometric 
measures  
Physiological tests 
Blood samples  
Anthropometric 
measures  
Physiological tests 
Extensive laboratory 
tests  
Stored samples of 
serum, plasma and 
DNA 
 
Follow-up As above As above, except for 
samples 
 
As above, except for 
samples 
 
On-going Mortality Mortality 
Cancer incidence 
Hospital admissions 
Mortality 
Cancer incidence 
Hospital admissions 
Mortality 
Cancer incidence 
Hospital admissions 
     
 
 
6. What is attrition like? 
 
About half of the members of the early cohorts were rescreened a few years after the initial 
screening (48% of Main, 46% of Collaborative and 55% of Renfrew/Paisley). All cohorts 
have been flagged for mortality with the General Register Office and we are informed of the 
small number of participants who emigrate. 
 
7. What has it found? Key findings and key publications 
 
Population Screening: The feasibility of the mass screening examination in healthy 
populations in a timely and cost efficient manner was first described and demonstrated2-4. 
Compared to previous UK studies, men in Renfrew/Paisley had shorter stature, higher blood 
pressure, a higher proportion of smokers continuing to smoke, lower forced expiratory 
volume in 1 second (FEV1), more angina (Rose questionnaire), higher breathlessness on 
effort and more chronic bronchitis5. Compared to Renfrew/Paisley men, Renfrew/Paisley 
women had higher plasma cholesterol, lower FEV1, fewer ever smokers and higher 
breathlessness on effort. Compared with the Whitehall study, the Collaborative and 
Renfrew/Paisley cohorts had higher mortality rates but these could be explained by the higher 
levels of smoking, poorer socioeconomic status, lower FEV1 and shorter stature in the west of 
Scotland cohorts6. 
 
Blood pressure: The Renfrew/Paisley study made a major contribution to the debate about 
whether a substantial reduction of diastolic blood pressure could lead to a significant decrease 
in mortality7. It was found that two blood pressure measurements are better than one for 
indicating stroke risk8.  
 
Cholesterol: Cholesterol was not a good indicator of all cause mortality, although there was a 
positive and close relationship with coronary heart disease9. There was no relationship 
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between cholesterol and overall stroke10. However, there was a significant inverse 
relationship between cholesterol and haemorrhagic stroke, and a J shaped relationship 
between cholesterol and ischaemic stroke. 
 
Smoking: The prevalence of respiratory symptoms increased with the number of cigarettes  
smoked and smokers had a mortality rate twice that of never smokers11. The Renfrew/Paisley 
cohort provided the first opportunity to examine the characteristics of a population group in 
Scotland in relation to their cigarette smoking habits in an area which at that time had the 
highest lung cancer incidence rate in the world12. Compared with other cohorts, the lung 
cancer rates were higher at all levels of cigarette smoking. Using linked data for participants 
living in the same household, the Renfrew/Paisley cohort was the first UK study to show the 
deleterious effects of passive smoking both in terms of reduced FEV1, increased 
symptomatology and poorer lung cancer and coronary heart disease (CHD) mortality amongst 
passive smokers13. 
 
Coronary Heart Disease: Coronary mortality in a representative population sample of 
women was examined and similarities with the known coronary risk factors found amongst 
men were established in women14. Another study examining the consistency of coronary risk 
factors for both men and women for both coronary disease and for stroke, highlighted 
similarities and differences15. CHD mortality rates over 15 years were quadrupled in people 
with two or more of Rose questionnaire angina, a previous history of CHD and/or ECG 
evidence of ischaemia16. Risk-mortality relationships were similar in men and women, with 
women having coronary events 15 years later than men. “Visible risk” (obesity and smoking) 
was a good predictor of CHD mortality17. “Unexplained” CHD deaths in men at low visible 
risk were rare, and usually associated with less visible risk factors. “Unwarranted survivals”, 
(i.e. despite being at high visible risk) were usually associated with more favourable profiles 
of less visible risk factors. “Exceptions to the rule” should not distract from the message that 
the differences in survival between high and low visible risk groups are dramatic. 
 
Stroke: Blood pressure, smoking, cardiothoracic ratio, pre-existing heart disease and diabetes 
were positively related to stroke mortality in 20 years and height and FEV1 were inversely 
related18. Stroke mortality rates in former smokers were similar to never smokers. Women’s 
stroke mortality rates were similar to men’s, unlike coronary heart disease mortality where 
women had lower rates than men. Risk factors for stroke in men and women had similar 
relationships with stroke incidence (measured by hospital admissions data), as with stroke 
mortality19. Poorer socio-economic circumstance was associated with greater stroke risk, with 
early life circumstances being of particular importance20. 
 
Respiratory: Impaired lung function was a major clinical indicator of mortality risk in men 
and women for a wide range of diseases, in addition to respiratory disease, an observation 
also found in lifelong non-smokers21. The effect of maternal and paternal smoking 
(documented over 20 years previously) on lung function in more than 2000 adult offspring 
was estimated22. There was a graded inverse association between maternal smoking and 
offspring FEV1, independent of offspring smoking, and no effect of paternal smoking on 
offspring FEV1. The Family Study has also provided the first evidence that maternal smoking 
synergises with personal smoking to increase airflow limitation and chronic obstructive 
pulmonary disease risk23. Identical questions answered by parents and their adult offspring 
showed a two-fold increase in the prevalence of asthma between the mid-1970s and the mid-
1990s, against the background of a rising prevalence of atopy24. 
 
Cancer: The main interest has been in lung cancer because of its high incidence locally.  
Analyses have established a higher risk per cigarette smoked generally in the population 
compared to other major cohort studies12, an increased link with social class not explained 
purely by the amount smoked25, and relationships with a range of variables, mostly 
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respiratory, indicating an increased susceptibility to the effects of cigarette smoke26; 27. 
Increasing non-linear risks of lung cancer with increasing tar levels have been demonstrated28. 
Repudiation of an underlying cancer risk in relation to blood pressure at a population level 
has been important in understanding varying cancer risks in some hypertensive patients29; 30. 
 
Qualitative studies about heart disease: Lay people may differ from health professionals in 
their perception of a family history of heart disease31. Working class men required a greater 
number of relatives to be affected before they perceived that they had a family history. 
Participants did not always regard themselves as being at risk if they felt different from 
affected relatives. CHD was perceived to be a male disease, with women remaining invisible 
in discourses about heart disease32. CHD was seen as a “good way to go”, compared with a 
painful and lingering death33. 
 
Alcohol: There was no relationship between mortality from coronary heart disease and 
alcohol consumption, after adjustments for potential confounders34. Drinkers of over 35 units 
per week had double the risk of stroke mortality compared with non drinkers. All cause 
mortality was higher in men drinking 22 units per week or more. 
 
Haemostasis: Use of hormone replacement therapy (HRT) tablets was associated with 
increased levels of some clotting factors (Factor IX, activated protein resistance and C-
reactive protein) and reduced levels of others (tissue plasminogen activator, plasminogen 
activator inhibitor). Transdermal HRT (i.e. “patches”) was not associated with these 
changes35. There was a negative association between birthweight and C-reactive protein in 
adulthood36. 
 
Early origins: Lower birthweight of offspring was associated with higher parental mortality 
from all causes and from cardiovascular disease37. This elevated mortality was not explained 
by a range of social, environmental, behavioural, and physiological risk factors. The strength 
of the association was greater than expected from the degree of concordance of birth weights 
across generations. Birthweight was positively associated with leg length, trunk length and 
total height38. Behavioural risk factors (cigarette smoking and recreational physical exercise) 
were more strongly associated with adult social circumstances than with childhood 
circumstances39. Physiological risk factors (diastolic blood pressure, cholesterol and FEV1) 
were associated to varying degrees with both childhood and adult circumstances. Having 
more siblings was related to adulthood disease risk, which could be explained by confounding 
risk factors, with the exception of stomach cancer mortality and haemorrhagic stroke40.  
 
Height: Taller people and those with good FEV1 experienced a reduced risk of CHD41. Leg 
length, an indicator of pre-pubertal nutritional status, was the component of height most 
strongly associated with risk. Height and FEV1 may both be markers of childhood exposures 
which influence growth and CHD risk. Greater height was associated with reduced risk of 
coronary heart disease, stroke and respiratory death42. Lung function was an important 
mediator of the association between height and cardiorespiratory mortality. Greater height 
was associated with increased risk of several cancers unrelated to smoking. The association 
between height and cancer may reflect the influence of calorie intake during childhood. There 
was a strong inverse relationship between height and haemorrhagic stroke and a weak, non-
significant relationship with ischaemic stroke43. 
 
Social class and lifecourse: Individual (social class) and area-based (deprivation category) 
socioeconomic measures were independently associated with risk factors, morbidity and 
mortality44. Health and risk of premature death were determined by socioeconomic factors 
acting throughout life45. Mortality from stroke and stomach cancer was particularly dependent 
on social circumstances in childhood, whereas mortality from coronary heart disease and 
respiratory disease was dependent on social circumstances in both adulthood and childhood46. 
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Mortality from accidents and violence and from lung cancer was mainly dependent on factors 
acting in adulthood. Socioeconomic and behavioural factors produced a cumulative influence 
on cardiovascular disease mortality risk47. Childhood and adulthood social class, smoking and 
heavy drinking explained about two thirds of the population burden of cardiovascular disease 
mortality in the west of Scotland. Occupational social class and education were both strongly 
associated with mortality48. Social environment in adulthood was the key determinant of 
smoking behaviour. Occupational social class was more strongly associated with overall and 
non-cardiovascular mortality than was the educational measure. The educational measure was 
more strongly associated with cardiovascular than with other causes of death. 
 
Stress and Psychosocial Factors: Stress in day-to-day life, measured by the Reeder stress 
index, was related in the expected direction to behavioural risk factors, such as smoking, 
alcohol drinking and lack of exercise – the more stress, the worse the risk factor profile49.  
This indicates that the stress measure correctly indexed the experience of stress. However 
when these data were collected – in the early 1970s – people in more favourable social 
circumstances reported higher levels of stress. This confounding led to stress being apparently 
protective with respect to later mortality50. People who reported high levels of stress also 
reported more adverse experiences with respect to other health measures, such as chest pain.  
This led to an apparent association between stress and angina – which was also reflected in 
hospital admissions, since people who go to the doctor complaining of chest pain are more 
likely to be admitted to hospital for suspected coronary heart disease - but the association was 
in the other direction with objective measures of coronary heart disease – ECG ischaemia and 
CHD mortality51. This demonstrates how reporting tendency can seriously compromise the 
interpretations of studies relating stress to fully subjective or partly subjective health 
outcomes. Persistent short sleep duration was associated with elevated all-cause and 
cardiovascular disease mortality52. 
 
Hospital admissions: 79% of the Renfrew/Paisley cohort experienced at least one acute 
hospital stay53. A high proportion of acute hospital bed days were required near to the time of 
death. For non-survivors, 42% of all acute episodes (55% of bed days) took place during the 
twelve months before death. Those who were at higher risk of admission were the older 
members of the cohort (especially men), those with low FEV1, smokers, those who were 
underweight or obese, the small number with abnormal levels of blood sugar, those with high 
blood pressure and those who lived in the most deprived areas. Preventive programmes which 
impact on these determinants of ill health may be useful in reducing hospital admission rates. 
 
 
8. What are the main strengths and weaknesses? 
 
Major strengths of the Midspan studies were the very large numbers of participants and the 
inclusion of women, at a time when other UK epidemiological studies included only men. An 
unplanned consequence of the Renfrew/Paisley study as a general population study with high 
response rates in a defined area, was the inclusion of many married couples and the 
possibility of a subsequent family study. General goodwill, study loyalty and the support of 
local family doctors made this a reality. Having occupational as well as general population 
cohorts in a similar location was another strength. The Collaborative study data were 
particularly suited for lifecourse studies as information was collected on socioeconomic 
factors in childhood and early adulthood. A salient feature of the whole enterprise has been 
continued follow-up either by re-examination or more comprehensively, by linkage to NHS 
mortality, cancer and other morbidity registers. Midspan has continued to attract the interests 
and participation of researchers from many disciplines and centres, whose achievements are 
given in the main list of references. 
 
A major weakness has been the lack of core funding. Midspan has been funded by a series of 
short-term grants. Continuity remains uncertain. Different variables were introduced and 
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dropped between studies, depending on current interests. It would have been preferable to 
have some of the variables that were only collected in the Collaborative study also collected 
in the other studies, in particular the lifecourse, stress and alcohol variables. Although the 
1996 study stored blood samples for future use, no samples were stored for the original 
studies. Blood samples were collected from surviving parents of Family study participants in 
2001, but only 556 were obtained, limiting future genetic studies. 
 
 
 
9. Can I get hold of the data? Where can I find out more? 
 
The data are available to experienced teams of researchers who have applied and been granted 
permission by the Midspan Steering Committee to use the data for a specific research 
proposal. Such work is conducted in collaboration with the Midspan team.  
 
For further details on how to apply for access to the data see -  
Procedure for Requests for Use of MIDSPAN Data in the Research section of the Midspan 
website: http://www.gla.ac.uk/faculties/medicine/midspan/ 
 
 
10. A complete list of publications 
This will go on the online version of the journal. 
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